Primary relevance to vitamin D Vitamin D is a stated subject of this paper.
Vitamin D is a stated subject of this paper; the supporting source evidence is shown below.
Why this paper is included
Supporting source evidence:
After 12 weeks, serum 25(OH)D significantly increased in the supplementation group compared with controls (Δ +23.7 vs +1.3 ng/mL; p < 0.001).
Source: Abstract. View original paper
Relevance classification does not establish study quality, causation or editorial approval.
Study design Cohort study.
Cohort study
Examines exposures and outcomes over time within a defined group.
Meta-analysis unclear · Blinding unclear / not reported · Human research reported
How this paper was classified
Automatic source-based classification; awaiting editorial verification. This is not a quality score.
This 12-week prospective cohort study was conducted in Poland during the autumn: winter season (October 1, 2024 to March 31, 2025).
Source: Methods.
Participants were recruited consecutively from a single outpatient metabolic clinic; all eligible patients attending routine follow-up visits during the recruitment period were screened and invited to participate, ensuring a non-selective recruitment process.
Source: Methods.
What the study types mean
- Systematic review
- Uses explicit methods to identify, assess and summarise research on a defined question.
- Scoping review
- Maps the extent and characteristics of research on a topic.
- Narrative review
- Discusses existing research; systematic-review methods have not been established by this classification.
- Review / evidence synthesis
- Reviews existing research; the exact review methods need further assessment.
- Randomised controlled trial
- Assigns participants or groups to comparison interventions by chance.
- Non-randomised intervention study
- Examines an intervention without random allocation.
- Cohort study
- Examines exposures and outcomes over time within a defined group.
- Case-control study
- Compares people with an outcome against people without it, examining exposures.
- Cross-sectional study
- Examines a population at a particular point in time.
- Observational study
- Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
- Case report
- Describes an individual case.
- Case series
- Describes a group of individual cases.
- Secondary analysis
- Analyses existing study data; this paper is not automatically another independent trial.
- Laboratory study
- Investigates biological processes in a laboratory setting.
- Qualitative study
- Examines experiences or meanings using qualitative methods.
- Genetic instrumental-variable study
- Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
- Study protocol
- Describes planned methods and is not evidence that the planned study has reported results.
- Multiple reported designs
- More than one design is explicitly reported; examine the supporting methods.
- Study design awaiting verification
- The available source does not establish a sufficiently clear study design.
Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.
Abstracts
Vitamin D supplementation and selected metabolic parameters in patients with type 2 diabetes and obesity: a prospective observational study
Cohort study · Frontiers in Endocrinology · 2026
Original publication title
Vitamin D supplementation and selected metabolic parameters in patients with type 2 diabetes and obesity: a prospective observational study
Copyright © 2026 Hoffmann, Bryl, Bhongade, Avagimyan, El-Tanani, Rabbani, Talath, Rangraze, Wali, Ibraheem, Satyam, Ispas, Ilias, Maggio, Rizzo and Paczkowska.
Original publication · Publisher record · CC BY 4.0
Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.
At a glance
Abstract: What objectives does the paper state?
To evaluate the effects of high-dose vitamin D3 supplementation on anthropometric and selected metabolic parameters in ambulatory obese patients with T2DM treated with metformin monotherapy.
Source: ObjectiveAbstract: What methods does the paper describe?
This 12-week prospective cohort study included 200 patients with T2DM, allocated to a supplementation group (n = 100; vitamin D3: 4,000 IU/day) or a control group (n = 100; no supplementation). Primary outcome was change in serum 25-hydroxyvitamin D [25(OH)D] concentration. Secondary outcomes included fasting serum glucose (FSG), glycated hemoglobin (HbA1c), blood pressure (BP), serum calcium, and body mass index (BMI). Predictors of failure to achieve target HbA1c ≤ 6.5% were identified using logistic regression.
Source: MethodsAbstract: Results
After 12 weeks, serum 25(OH)D significantly increased in the supplementation group compared with controls (Δ +23.7 vs +1.3 ng/mL; p < 0.001). FSG and HbA1c decreased significantly in the intervention group (Δ: 0.4 mmol/L, p = 0.02; Δ: 0.6%, p = 0.01, respectively), while no significant changes were observed in systolic or diastolic BP, serum calcium, or BMI. Logistic regression identified higher baseline FSG (OR 1.34, 95% CI 1.12 to 1.61), longer diabetes duration (OR 1.28, 95% CI 1.07 to 1.54), and higher BMI (OR 1.21, 95% CI 1.01 to 1.47) as independent predictors of suboptimal glycemic response.
Source: ResultsAbstract: Conclusions
High-dose vitamin D3 supplementation significantly improved vitamin D status and was associated with modest improvements in glycemic control in obese patients with T2DM, without affecting blood pressure, calcium, or body weight. These findings support vitamin D repletion as a potential adjunctive strategy in diabetes management, while not allowing causal inference, and warrant further confirmation in randomized controlled trials with longer follow-up.
Source: ConclusionsAuthors’ abstract
Introduction
Vitamin D deficiency has been implicated in metabolic dysregulation, including insulin resistance and inflammation, commonly observed in patients with type 2 diabetes mellitus (T2DM) and obesity. Evidence on the metabolic impact of vitamin D supplementation in this population remains inconsistent.
Objective
To evaluate the effects of high-dose vitamin D3 supplementation on anthropometric and selected metabolic parameters in ambulatory obese patients with T2DM treated with metformin monotherapy.
Methods
This 12-week prospective cohort study included 200 patients with T2DM, allocated to a supplementation group (n = 100; vitamin D3: 4,000 IU/day) or a control group (n = 100; no supplementation). Primary outcome was change in serum 25-hydroxyvitamin D [25(OH)D] concentration. Secondary outcomes included fasting serum glucose (FSG), glycated hemoglobin (HbA1c), blood pressure (BP), serum calcium, and body mass index (BMI). Predictors of failure to achieve target HbA1c ≤ 6.5% were identified using logistic regression.
Results
After 12 weeks, serum 25(OH)D significantly increased in the supplementation group compared with controls (Δ +23.7 vs +1.3 ng/mL; p < 0.001). FSG and HbA1c decreased significantly in the intervention group (Δ: 0.4 mmol/L, p = 0.02; Δ: 0.6%, p = 0.01, respectively), while no significant changes were observed in systolic or diastolic BP, serum calcium, or BMI. Logistic regression identified higher baseline FSG (OR 1.34, 95% CI 1.12 to 1.61), longer diabetes duration (OR 1.28, 95% CI 1.07 to 1.54), and higher BMI (OR 1.21, 95% CI 1.01 to 1.47) as independent predictors of suboptimal glycemic response.
Conclusions
High-dose vitamin D3 supplementation significantly improved vitamin D status and was associated with modest improvements in glycemic control in obese patients with T2DM, without affecting blood pressure, calcium, or body weight. These findings support vitamin D repletion as a potential adjunctive strategy in diabetes management, while not allowing causal inference, and warrant further confirmation in randomized controlled trials with longer follow-up.
Publication and source details
Original title: Vitamin D supplementation and selected metabolic parameters in patients with type 2 diabetes and obesity: a prospective observational study
Karolina Hoffmann; Wiesław Bryl; Bhoomendra Bhongade; Ashot Avagimyan; Mohammed El-Tanani; Syed Arman Rabbani; Sirajunisa Talath; Imran Rashid Rangraze; Adil Farooq Wali; Walaa Ibraheem; Shakta Mani Satyam; Sorina Ispas; Ioannis Ilias; Viviana Maggio; Manfredi Rizzo; Anna Paczkowska
Frontiers in Endocrinology · 2026
* Correspondence: Karolina Hoffmann, karolinahoffmann@ump.edu.plCopyright © 2026 Hoffmann, Bryl, Bhongade, Avagimyan, El-Tanani, Rabbani, Talath, Rangraze, Wali, Ibraheem, Satyam, Ispas, Ilias, Maggio, Rizzo and Paczkowska.2026Hoffmann, Bryl, Bhongade, Avagimyan, El-Tanani, Rabbani, Talath, Rangraze, Wali, Ibraheem, Satyam, Ispas, Ilias, Maggio, Rizzo and Paczkowskahttps://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.The author(s) declared that financial support was not received for this work and/or its publication.Repository JATS snapshot; version as supplied
Source retrieved: 2026-11-11T00:21:49.117197+00:00
DOI: 10.3389/fendo.2025.1750040 · PMC12847046